Daniel Garber, MD
Sleep Medicine · Concord, NCNPI 1801997259
Payments from drug & device makers
Across 822 payments — averaging $3221.80 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.
- Takeda Pharmaceuticals U.S.A., Inc.$2.2M
- Alkermes, Inc.$387K
- Harmony Biosciences LLC$99K
- Eisai Inc.$2K
- Jazz Pharmaceuticals Inc.$307
- Idorsia Pharmaceuticals US Inc$139
- plus $110 from 3 others
What the payments were for
- Travel & lodging$4,98877%
- Food & beverage$1,28120%
- Education$2143%
General payments by program year
Who reported the general payments
Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.
| Company | Payments | Total |
|---|---|---|
| Takeda Pharmaceuticals U.S.A., Inc. | 427 | $2,159,187 |
| Alkermes, Inc. | 308 | $387,113 |
| Harmony Biosciences LLC | 53 | $99,475 |
| Eisai Inc. | 21 | $1,989 |
| Jazz Pharmaceuticals Inc. | 7 | $307 |
| Idorsia Pharmaceuticals US Inc | 2 | $139 |
| Avadel CNS Pharmaceuticals, LLC | 2 | $41 |
| Inspire Medical Systems, Inc. | 1 | $37 |
| Itamar Medical Inc | 1 | $32 |
What the payments were tied to
Products named in the reported payments. Only payments of $100 or more are attributed here — the typical reported payment nationally is a meal worth about $16, and listing those product-by-product would be noise.
- QUVIVIQ$125
How this compares
$2,648,320 in reported general payments places this provider in the 95th percentile of 52 sleep medicine providers in North Carolina.
Medicare billing
What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.
Most prescribed under Part D
| Drug | Claims | Cost to plans & patients |
|---|---|---|
| Armodafinil | 11 | $1,073 |
| Pramipexole DihydrochloridePramipexole Di-Hcl | 53 | $662 |
| Zolpidem Tartrate | 12 | $225 |
Paid to pharmacies, not to this prescriber.
Other sleep medicine in Concord
- Shubekchha AryalConcord$1K
- Mark LeticaConcord$12
- Omavi BaileyFayetteville$246K
- Jamila BattleRaleigh$124K
- Marjorie SoltisDurham$48K
- Douglas KirschCharlotte$26K
- Diana AlexandruGreenville$6K
- Jan KriskaMount Airy$6K
- Cameron BarberCary$5K
- Pallavi ReddyBurlington$3K
Where these figures come from
- Payments: CMS Open Payments, program years 2019–2025 (publication P06302026_06032026).
- Billing: Medicare Physician & Other Practitioners, data year 2024. Original Medicare Part B only.
- Identity: NPPES NPI Registry, July 2026.